Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Gary L Norman"'
Autor:
Gyorgy Kovacs, Nora Sipeki, Boglarka Suga, Tamas Tornai, Kai Fechner, Gary L Norman, Zakera Shums, Peter Antal-Szalmas, Maria Papp
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194166 (2018)
To determine the prognostic potential of classic and novel serologic antibodies regarding unfavorable disease course in a prospective ulcerative colitis (UC) patient cohort, since few and conflicting data are available in the literature regarding thi
Externí odkaz:
https://doaj.org/article/904f01f619fc485bb47f8b882c903ee3
Autor:
Henry H Nguyen, Abdel Aziz Shaheen, Natalia Baeza, Ellina Lytvyak, Stefan J Urbanski, Andrew L Mason, Gary L Norman, Marvin J Fritzler, Mark G Swain
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193960 (2018)
Up to 20% of Primary Biliary Cholangitis (PBC) patients are estimated to have features that overlap with Autoimmune Hepatitis (AIH). Patients with PBC-AIH overlap syndrome (PBC-AIH OS) have been reported to exhibit suboptimal responses to ursodeoxych
Externí odkaz:
https://doaj.org/article/f2f5960b7bca4220a2f0d9f90e591581
Autor:
Laura M Stinton, Chelsea Bentow, Michael Mahler, Gary L Norman, Bertus Eksteen, Andrew L Mason, Gilaad G Kaplan, Bjorn Lindkvist, Gideon M Hirschfield, Piotr Milkiewicz, Angela Cheung, Harry L A Janssen, Marvin J Fritzler
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112877 (2014)
BACKGROUND AND AIMS:The only recognized biomarker for primary sclerosing cholangitis (PSC) is atypical anti-neutrophil cytoplasmic antibodies (aANCA), which, in addition to having low sensitivity and specificity, is an indirect immunofluorescence (II
Externí odkaz:
https://doaj.org/article/9bf9e6a40fb049ad865ef9fd8f366ef1
Autor:
Michael T Mullen, Steven R Messé, Scott E Kasner, Lauren eSansing, M Rizwan Husain, Gary L Norman, Zakera eShums, Brett L Cucchiara
Publikováno v:
Frontiers in Neurology, Vol 3 (2012)
Background: Antiphospholipid antibodies (aPLs) have been associated with thrombosis in the antiphospholipid antibody syndrome (APS) and with atherosclerotic vascular events in patients without APS. We examined the significance of aPLs in transient is
Externí odkaz:
https://doaj.org/article/8658eee7d7904266b6e0ee5c4f50acc6
Autor:
Maria Papp, Gary L Norman, Zsuzsanna Vitalis, Istvan Tornai, Istvan Altorjay, Ildiko Foldi, Miklos Udvardy, Zakera Shums, Tamas Dinya, Peter Orosz, Bela Lombay, Gabriella Par, Alajos Par, Gabor Veres, Timea Csak, Janos Osztovits, Ferenc Szalay, Peter Laszlo Lakatos
Publikováno v:
PLoS ONE, Vol 5, Iss 9, p e12957 (2010)
BACKGROUND: Bacterial translocation plays important role in the complications of liver cirrhosis. Antibody formation against various microbial antigens is common in Crohn's disease and considered to be caused by sustained exposure to gut microflora c
Externí odkaz:
https://doaj.org/article/bdc5b0c749af4df7be6c080239366ea0
Autor:
Petra Kriķe, Zakera Shums, Inese Poļaka, Ilze Kikuste, Aigars Vanags, Ivars Tolmanis, Sergejs Isajevs, Inta Liepniece-Karele, Daiga Santare, Lilian Tzivian, Dace Rudzīte, Minkyo Song, M. Constanza Camargo, Gary L. Norman, Mārcis Leja
Publikováno v:
Diagnostics, Vol 12, Iss 11, p 2784 (2022)
We aimed to determine the diagnostic value of anti-parietal cell antibodies (anti-PCA), anti-intrinsic factor antibodies (anti-IFA), pepsinogen ratio (PGI/II), and gastrin-17 (G-17) in corpus-restricted atrophic gastritis (CRAG) detected by ELISA (In
Externí odkaz:
https://doaj.org/article/8c3b31334ccb4bad862bc0f2a049bdce
Autor:
Maria Infantino, Mariangela Manfredi, Maria Grazia Alessio, Giulia Previtali, Valentina Grossi, Maurizio Benucci, Antonio Faraone, Alberto Fortini, Elisa Grifoni, Luca Masotti, Edda Russo, Amedeo Amedei, Emily FitzGerald, Roger Albesa, Gary L. Norman, Michael Mahler
Publikováno v:
Journal of medical virologyREFERENCES. 94(12)
Calprotectin (S100A8/A9) has been identified as a biomarker that can aid in predicting the severity of disease in COVID-19 patients. This study aims to evaluate the correlation between levels of circulating calprotectin (cCP) and the severity of COVI
Autor:
Yu Zuo, Sherwin Navaz, Wenying Liang, Chun Li, Colby R. Ayers, Christine E. Rysenga, Alyssa Harbaugh, Gary L. Norman, E. Blair Solow, Bonnie Bermas, Oludamilola Akinmolayemi, Anand Rohatgi, David R. Karp, Jason S. Knight, James A. de Lemos
Publikováno v:
JAMA Network Open. 6:e236530
ImportanceThe prevalence of antiphospholipid antibodies (aPL) and their association with future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly investigated.ObjectiveTo determine the association between measurements of aP
Autor:
Vincent Ricchiuti, Kelly Y. Chun, Jane M. Yang, Mary Ann Aure, Luis Gomez, Gary L. Norman, Michael Mahler
Publikováno v:
Diagnostics (Basel, Switzerland). 12(7)
(1) Background: Anti-carbamylated protein (CarP) antibodies have been studied as novel markers to aid in the diagnosis and prognosis of rheumatoid arthritis. (2) Methods: A total of 265 samples were included in the evaluation, for which 98 had result
Autor:
Andre Franke, Malgorzata Milkiewicz, Gary L. Norman, Christoph Schramm, Michael Mahler, Zakera Shums, Steffi Lopens, Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Chelsea Bentow, Dirk Roggenbuck, Dirk Reinhold
Publikováno v:
Alimentary Pharmacology & Therapeutics
Background Primary sclerosing cholangitis (PSC) is associated with progressive liver disease and cholangiocarcinoma. Although risk stratification is crucial for making clinical decisions, it is hindered by a scarcity of proven prognostic markers. Aim